The Washington Post, December 3, 2010. However, this worries NCHR President: “We do patients no favors when we sell them implanted medical products that have been tested on just a few patients for only one year.”
Read More »News That Quotes Us & Our Work
We are often quoted in major newspapers and magazines, and on well-respected TV shows, radio programs, and websites where we share our opinion on issues that matter to you and your health. Stay up to date on health news and our take on it by reading the articles in this section.
F.D.A. Rejects Qnexa, a Third Weight-Loss Drug
New York Times, October 29, 2010. FDA requested the company provide thorough evaluation of the drug’s potential for causing birth defects and heart problems.
Read More »Glaxo’s Avandia to Be Pulled From EU Market, Restricted in U.S.
Bloomberg, September 23, 2010. GlaxoSmithKline Plc‘s Avandia, once the world’s best-selling diabetes drug, will be withdrawn in Europe and restricted in the U.S. after a three-year review of the medicine’s heart risks.
Read More »Does Avandia Decision Signal New FDA? Or Same Old Agency?
NPR, September 23, 2010. The Europeans are suspending sales of the controversial diabetes drug Avandia because of evidence it may cause serious heart problems. American regulators are letting it stay on the market, with restrictions.
Read More »Medical Devices That Can Kill
Reader’s Digest, September 2010. In 2009, a study by Congress’s Government Accountability Office found that the safety and efficacy of many of the riskiest devices on the market have never been proved. The FDA’s oversight of medical products is broken.
Read More »